China Dasheng Biotechnology (CDBT) Stock Price, News & Analysis

Company Overview

China Dasheng Biotechnology Inc. (OTCMKTS:CDBT) is a life sciences company specializing in the research, development and manufacture of biotechnology products. The company’s core operations focus on molecular diagnostic reagents, cell culture media and related laboratory supplies. Through its in-house R&D programs, China Dasheng has built a portfolio of real-time PCR kits, nucleic acid extraction systems and immunoassay reagents that support disease detection, genetic research and quality control applications.

China Dasheng’s product range encompasses pre-packaged reagents for pathogen detection, gene expression analysis and genetic marker screening. The company also offers customized solutions for academic institutions, clinical laboratories and industrial biotechnology firms. In addition to off-the-shelf kits, China Dasheng provides technical support, training services and laboratory validation to ensure seamless adoption of its diagnostic platforms.

Headquartered in Jinan, Shandong Province, the company serves customers across mainland China with an expanding footprint in select international markets. Its distribution network extends to public health agencies, hospital systems and private research centers. China Dasheng has pursued strategic partnerships with regional distributors and established quality management systems compliant with international in vitro diagnostics standards.

Since its founding in the early 2000s, China Dasheng has emphasized innovation and regulatory compliance in the life sciences sector. The management team brings together experienced professionals in molecular biology, clinical diagnostics and business development. With ongoing investment in R&D infrastructure, the company aims to broaden its diagnostic offerings and deepen collaborations with academic and industry partners.

Key Stats

• Today's Range: $0.04 to $0.05
• 50-Day Range: $0.03 to $0.15
• 52-Week Range: $0.00 to $0.15
• Volume: 18,092 shs
• Average Volume: 12,561 shs
• Market Capitalization: $1.64 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CDBT Stock Analysis - Frequently Asked Questions

How have CDBT shares performed this year?

China Dasheng Biotechnology's stock was trading at $0.0610 at the beginning of the year. Since then, CDBT stock has decreased by 34.4% and is now trading at $0.04.

How do I buy shares of China Dasheng Biotechnology?

Shares of CDBT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of China Dasheng Biotechnology own?

Based on aggregate information from My MarketBeat watchlists, some other companies that China Dasheng Biotechnology investors own include Allied Gaming & Entertainment (AGAE), Avino Silver & Gold Mines (ASM), Academy Sports and Outdoors (ASO), Berkeley Energia (BKY), Global X Cloud Computing ETF (CLOU), VelocityShares 1x Long VSTOXX Futures ETN (EVIX) and First Trust United Kingdom AlphaDEX Fund (FKU).

Company Calendar

• Today: 7/12/2025
• Fiscal Year End: 6/30/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Basic Materials
• Industry: Drug stores & proprietary stores
• Sub-Industry: Retail
• Current Symbol: OTCMKTS:CDBT
• CIK: N/A
• Web: N/A
• Phone: (424) 358-1046
• Fax: 86-93-1844-1248
• Employees: 689
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: 40,976,000
• Free Float: N/A
• Market Cap: $2.05 million
• Optionable: Not Optionable
• Beta: 2.25